Intravenous immune globulin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Bone marrow transplant (to prevent graft vs host disease)
  • Primary immunoglobulin deficiency
  • Idiopathic thrombocytopenia (ITP)
  • Prevention of bacterial infections in HIV-infected children who are not receiving prophylaxis (FDA approved but generally not recommended); Kawasaki disease.
  • VZV post-exposure prophylaxis (if Varicella-Zoster immune globulin is not available)

NON-FDA APPROVED USES

  • Anemia due to parvovirus B19 infection.
  • Non-FDA approved indications with established efficacy: Guillain-Barre syndrome; steroid resistant dermatomyositis; multifocal motor neuropathy.
  • Non-FDA approved indications that is still controversial: patients with Strep TSS treated with IVIG had a trend toward a lower mortality rate.
  • Severe C. difficile-associated colitis (based on case reports) .

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 2, 2011